Cited by 63Viral Infections and Immunology ResearchCardiac Fibrosis and RemodelingOcular Diseases and Behçet’s Syndrome

Autoimmune Myocarditis, Valvulitis, and Cardiomyopathy

Open access
Myers, Jennifer M., Fairweather, DeLisa, Huber, Sally A., Cunningham, Madeleine W.·2013·Current Protocols in Immunology

Abstract

Myocarditis and valvulitis are inflammatory diseases affecting myocardium and valve. Myocarditis, a viral‐induced disease of myocardium, may lead to dilated cardiomyopathy and loss of heart function. Valvulitis leads to deformed heart valves and altered blood flow in rheumatic heart disease. Animal models recapitulating these diseases are important in understanding the human condition. Cardiac myosin is a major autoantigen in heart, and antibodies and T cells to cardiac myosin are evident in inflammatory heart diseases. This unit is a practical guide to induction and evaluation of experimental autoimmune myocarditis (EAM) in several mouse strains and the Lewis rat. Purification protocols for cardiac myosin and protocols for induction of EAM by cardiac myosin and its myocarditis‐producing peptides, and coxsackievirus CVB3, are defined. Protocols for assessment of myocarditis and valvulitis in humans and animal models provide methods to define functional autoantibodies targeting cardiac myosin, β‐adrenergic, and muscarinic receptors, and their deposition in tissues. Curr. Protoc. Immunol . 101:15.14.1‐15.14.51. © 2013 by John Wiley & Sons, Inc.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/0471142735.im1514s101

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Lewis rats immunized with cardiac myosin develop experimental autoimmune myocarditis with multinucleated giant cells, replicating clinical findings in giant cell myocarditis.

    “The immunized rats developed EAM with multinucleated giant cells, replicating clinical findings in giant cell myocarditis.”

    From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [192]

    Basic Protocol 2 (page not available) states that immunization with cardiac myosin elicits EAM in Lewis rats. The histopathological assessment protocol describes infiltrating mononuclear cells, but our copy does not report multinucleated giant cells in these rats or say that their lesions replicate clinical giant cell myocarditis. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 137 · Cited by 63

Research works printed but not linked: 114

  1. Abston ED Barin JG 2012 IL-33 Independently Induces Eosinophilic Pericarditis and Cardiac Dilation: ST2 Improves Cardiac Function Circ Heart Fail 5 3 366 375 22454393 PMC3874395
  2. Adams JE 3rd Abendschein DR 1993 Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation 88 2 750 763 8339435
  3. Afanasyeva M Wang Y 2001 Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype Am J Pathol 159 1 193 203 11438466 PMC1850414
  4. Aretz HT 1987 Myocarditis: the Dallas criteria Hum Pathol 18 6 619 624 3297992
  5. Aretz HT Billingham ME 1987 Myocarditis. A histopathologic definition and classification Am J Cardiovasc Pathol 1 1 3 14 3455232
  6. Bachmaier K Mair J 1995 Serum cardiac troponin T and creatine kinase-MB elevations in murine autoimmune myocarditis Circulation 92 7 1927 1932 7671377
  7. Bachmaier K Neu N 1999 Chlamydia infections and heart disease linked through antigenic mimicry Science 283 5406 1335 1339 10037605
  8. Bowles NE Richardson PJ 1986 Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy Lancet 1 8490 1120 1123 2871380
  9. Brown CA O’Connell JB 1995 Myocarditis and idiopathic dilated cardiomyopathy Am J Med 99 3 309 314 7653492 PMC7119456
  10. Caforio AL Goldman JH 1996 Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives Int J Cardiol 54 2 157 163 8803680
  11. Caforio AL Mahon NJ 2001 Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy Autoimmunity 34 3 199 204 11908778
  12. Cameron-Wilson CL Zhang H 2002 A vector with transcriptional terminators increases efficiency of cloning of an RNA virus by reverse transcription long polymerase chain reaction J Mol Microbiol Biotechnol 4 2 127 131 11873908
  13. Chapman NM Tu Z 1994 An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses Arch Virol 135 1–2 115 130 8198437
  14. Chiale PA Ferrari I 2001 Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction Circulation 103 13 1765 1771 11282908
  15. Cihakova D Barin JG 2008 Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation Am J Pathol 172 5 1195 1208 18403598 PMC2329830
  16. Cihakova D Rose NR 2008 Pathogenesis of myocarditis and dilated cardiomyopathy Adv Immunol 99 95 114 19117533
  17. Cooper LT Jr 2009 Myocarditis N Engl J Med 360 15 1526 1538 19357408 PMC5814110
  18. Cornell CT Kiosses WB 2007 Coxsackievirus B3 proteins directionally complement each other to downregulate surface major histocompatibility complex class I J Virol 81 13 6785 6797 17442717 PMC1933326
  19. Coronado MJ Brandt JE 2012 Testosterone and interleukin-1beta increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n Am J Physiol Heart Circ Physiol 302 8 H1726 1736 22328081 PMC3330806
  20. Cunningham MW Antone SM 1992 Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin Proc Natl Acad Sci U S A 89 4 1320 1324 1311095 PMC48441
  21. Cunningham MW Antone SM 1997 Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein Infect Immun 65 9 3913 3923 9284171 PMC175558
  22. Cunningham MW Meissner HC 1999 Anti-human cardiac myosin autoantibodies in Kawasaki syndrome Journal of Immunology 163 2 1060 1065 10395705
  23. Diederich KW Eisele I 1989 Isolation and characterization of the complete human beta-myosin heavy chain gene Hum Genet 81 3 214 220 2522082
  24. Donermeyer DL Beisel KW 1995 Myocarditis-inducing epitope of myosin binds constitutively and stably to I-A K on antigen presenting cells in the heart Journal of Experimental Medicine 182 1291 1300 7595200 PMC2192215
  25. Dunn JJ Chapman NM 2000 Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5’ nontranslated region J Virol 74 10 4787 4794 10775617 PMC112001
  26. Elamm C Fairweather D 2012 Pathogenesis and diagnosis of myocarditis Heart 98 11 835 840 22442199 PMC12767484
  27. Ellis NMJ Li Y 2005 T cell mimicry and epitope specificity of crossreactive T cell clones from rheumatic heart disease J Immunol 175 5448 5456 16210652
  28. Eriksson U Kurrer MO 2001 Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myocarditis: induction by IL-12 and protection by IFN-gamma J Immunol 167 9 5464 5469 11673566
  29. Fae KC da Silva DD 2006 Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease J Immunol 176 9 5662 5670 16622036
  30. Fairweather D Frisancho-Kiss S 2004 Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart Am J Pathol 165 6 1883 1894 15579433 PMC1618717
  31. Fairweather D Frisancho-Kiss S 2005 IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart J Immunol 174 1 261 269 15611248
  32. Fairweather D Rose NR 2007 Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity Methods 41 1 118 122 17161308 PMC1764911
  33. Felker GM Hu W 1999 The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients Medicine 78 270 283 10424207
  34. Feuer R Mena I 2002 Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro J Virol 76 9 4430 4440 11932410 PMC155066
  35. Fischetti VA Jones KF 1984 Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein J Exp Med 159 4 1083 1095 6368734 PMC2187285
  36. Frisancho-Kiss S Coronado MJ 2009 Gonadectomy of male BALB/c mice increases Tim-3(+) alternatively activated M2 macrophages, Tim-3(+) T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis Brain Behav Immun 23 5 649 657 19126426 PMC3148833
  37. Fuse K Chan G 2005 Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production Circulation 112 15 2276 2285 16216974
  38. Galvin JE Hemric ME 2002 Induction of myocarditis and valvulitis in Lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis Am J Pathol 160 1 297 306 11786423 PMC1867128
  39. Guilherme L Kalil J 2006 Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease Autoimmunity 39 1 31 39 16455580
  40. Guthrie M Lodge PA 1984 Cardiac injury in myocarditis induced by Coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2 + cytolytic lymphocytes Cell Immunol 88 2 558 567 6091924
  41. Hanawa H Tsuchida M 1993 Characterization of T cells infiltrating the heart in rats with experimental autoimmune myocarditis. Their similarity to extrathymic T cells in mice and the site of proliferation J Immunol 150 12 5682 5695 8515083
  42. Henke A Huber S 1995 The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis J Virol 69 11 6720 6728 7474082 PMC189582
  43. Herskowitz A Wolfgram LJ 1987 Coxsackievirus B3 murine myocarditis: a pathologic spectrum of myocarditis in genetically defined inbred strains J Am Coll Cardiol 9 6 1311 1319 3034991
  44. Horwitz MS La Cava A 2000 Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis Nature Med 6 693 697 10835688
  45. Huber S Sartini D 2005 T cells expressing the Vgamma1 T-cell receptor enhance virus-neutralizing antibody response during coxsackievirus B3 infection of BALB/c mice: differences in male and female mice Viral Immunol 18 4 730 739 16359239
  46. Huber S Sartini D 2003 Role of CD1d in coxsackievirus B3-induced myocarditis J Immunol 170 6 3147 3153 12626572
  47. Huber SA 1997 Autoimmunity in myocarditis: relevance of animal models Clin Immunol Immunopathol 83 2 93 102 9143370
  48. Huber SA 1997 Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice Lab Invest 76 5 691 701 9166288
  49. Huber SA 2005 Increased susceptibility of male BALB/c mice to coxsackievirus B3-induced myocarditis: role for CD1d Med Microbiol Immunol 194 3 121 127 15107990
  50. Huber SA 2009 Depletion of gammadelta+ T cells increases CD4+ FoxP3 (T regulatory) cell response in coxsackievirus B3-induced myocarditis Immunology 127 4 567 576 19604307 PMC2729534
  51. Huber SA Cunningham MW 1996 Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsakieviral myocarditis J Immunol 156 9 3528 3534 8617982
  52. Huber SA Gauntt CJ 1998 Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity Adv Virus Res 51 35 80 9891585
  53. Huber SA Moraska A 1994 Alterations in major histocompatibility complex association of myocarditis induced by coxsackievirus B3 mutants selected with monoclonal antibodies to group A streptococci Proc Natl Acad Sci U S A 91 12 5543 5547 8202524 PMC44032
  54. Huber SA Pfaeffle B 1994 Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3 J Virol 68 8 5126 5132 8035512 PMC236456
  55. Huber SA Sartini D 2005 Roles of tumor necrosis factor alpha (TNF-alpha) and the p55 TNF receptor in CD1d induction and coxsackievirus B3-induced myocarditis J Virol 79 5 2659 2665 15708985 PMC548425
  56. Inomata T Hanawa H 1995 Localization of porcine cardiac myosin epitopes that induce experimental autoimmune myocarditis Circ Res 76 5 726 733 7537184
  57. Jaenicke T Diederich KW 1990 Complete sequence of human β myosin Genomics 8 194 207 2249844
  58. Kandolf R Hofschneider PH 1985 Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells Proc Natl Acad Sci U S A 82 14 4818 4822 2410905 PMC390996
  59. Karp CL Grupe A 2000 Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma Nat Immunol 1 3 221 226 10973279
  60. Katus HA Remppis A 1991 Diagnostic efficiency of troponin T measurements in acute myocardial infarction Circulation 83 3 902 912 1999039
  61. Kaya Z Dohmen KM 2002 Cutting edge: a critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis J Immunol 168 4 1552 1556 11823481
  62. Kemball CC Harkins S 2009 Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway PLoS Pathog 5 10 e1000618 19834548 PMC2757675
  63. Kindermann I Kindermann M 2008 Predictors of outcome in patients with suspected myocarditis Circulation 118 6 639 648 18645053
  64. Knowlton KU Jeon ES 1996 A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3 J Virol 70 11 7811 7818 8892902 PMC190851
  65. Kodama M Matsumoto Y 1990 A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction Clin Immunol Immunopathol 57 2 250 262 2208806
  66. Kohno K Takagaki Y 2001 A peptide fragment of beta cardiac myosin heavy chain (beta-CMHC) can provoke autoimmune myocarditis as well as the corresponding alpha cardiac myosin heavy chain (alpha-CMHC) fragment Autoimmunity 34 3 177 185 11908775
  67. Kohno K Takagaki Y 2000 Advantage of recombinant technology for the identification of cardiac myosin epitope of severe autoimmune myocarditis in Lewis rats Jpn Heart J 41 67 77 10807531
  68. Krisher K Cunningham MW 1985 Myosin: a link between streptococci and heart Science 227 4685 413 415 2578225
  69. Kuhl U Pauschinger M 2005 “High prevalence of viral genomes and multiple viral infections in the myocardium of adults with idiopathic” left ventricular dysfunction Circulation 111 7 887 893 15699250
  70. Lauer B Padberg K 1994 Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis J Am Coll Cardiol 23 146 153 8277073
  71. Lawson CM 2000 Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis Cell Mol Life Sci 57 4 552 560 11130455 PMC11146955
  72. Lee C Maull E 1997 Generation of an infectious cDNA of a highly cardiovirulent coxsackievirus B3(CVB3m) and comparison to other infectious CVB3 cDNAs Virus Res 50 2 225 235 9282787
  73. Li Y Heuser JS 2004 Protection against experimental autoimmune myocarditis is mediated by IL-10 producing T cells that are controlled by dendritic cells Amer J Pathol 167 5 15 15972947 PMC1603447
  74. Lodge PA Herzum M 1987 Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms Am J Pathol 128 3 455 463 2957924 PMC1899672
  75. Lyden D Olszewski J 1987 Variation in susceptibility of Balb/c mice to coxsackievirus group B type 3-induced myocarditis with age Cell Immunol 105 2 332 339 3494528
  76. Lyden DC Olszewski J 1987 Coxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes Am J Pathol 126 3 432 438 3030117 PMC1899641
  77. Maisch B Deeg P 1983 Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy Am J Cardiol 52 8 1072 1078 6356861
  78. Maisch B Trostel-Soeder R 1982 Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis Clin Exp Immunol 48 3 533 545 6288291 PMC1536618
  79. Mascaro-Blanco A Alvarez K 2008 Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies Autoimmunity 41 6 442 453 18781470 PMC3108569
  80. Matsumori A 2005 Hepatitis C virus infection and cardiomyopathies Circ Res 96 2 144 147 15692092
  81. Matsumori A Shimada T 2006 Myocarditis and heart failure associated with hepatitis C virus infection J Card Fail 12 4 293 298 16679263
  82. McManus BM Chow LH 1993 Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis Clin Immunol Immunopathol 68 2 159 169 7689428
  83. McNamara DM Starling RC 2011 Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study J Am Coll Cardiol 58 11 1112 1118 21884947 PMC6467576
  84. Moseley TA Haudenschild DR 2003 Interleukin-17 family and IL-17 receptors Cytokine Growth Factor Rev 14 2 155 174 12651226
  85. Neu N Beisel KW 1987 Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to coxsackievirus B3 induced myocarditis Journal of Immunology 138 2488 2492 3031159
  86. Neu N Rose NR 1987 Cardiac myosin induces myocarditis in genetically predisposed mice J Immunol 139 11 3630 3636 3680946
  87. Neumann DA Burek CL 1990 Circulating heart reactive antibodies in patients with myocarditis or cardiomyopathy J Am Coll Cardiol 16 839 846 2229805
  88. Onyimba JA Coronado MJ 2011 The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice Biol Sex Differ 2 2 21338512 PMC3049118
  89. Opavsky MA Penninger J 1999 Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection Circ Res 85 6 551 558 10488058
  90. Penninger JM Neu N 1993 Induction of experimental autoimmune myocarditis in mice lacking CD4 or CD8 molecules J Exp Med 178 1837 1842 8228830 PMC2191227
  91. Poffenberger MC Straka N 2009 Lack of IL-6 during coxsackievirus infection heightens the early immune response resulting in increased severity of chronic autoimmune myocarditis PLoS One 4 7 e6207 19587788 PMC2703827
  92. Pummerer CL Luze K 1996 Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice J Clin Invest 97 9 2057 2062 8621795 PMC507280
  93. Quinn-Laquer BK Kennedy JE 1992 Characterization of the allelic differences in the mouse cardiac alpha-myosin heavy chain coding sequence Genomics 13 1 176 188 1577481
  94. Quinn A Kosanke S 2001 Induction of autoimmune valvular heart disease by recombinant streptococcal m protein Infect Immun 69 6 4072 4078 11349078 PMC98471
  95. Roberts S Kosanke S 2001 Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium J Infect Dis 183 3 507 511 11133385
  96. Rose NR Herskowitz A 1993 Autoimmunity in myocarditis: models and mechanisms Clin Immunol Immunopathol 68 2 95 99 8395364
  97. Rose NR Wolfgram LJ 1986 Postinfectious autoimmunity: two distinct phases of coxsackievirus B3-induced myocarditis Ann N Y Acad Sci 475 146 156 3024549
  98. Saez LJ Gianola KM 1987 Human cardiac myosin heavy chain genes and their linkage in the genome Nucleic Acids Res 15 13 5443 5459 3037493 PMC305971
  99. Slifka MK Pagarigan R 2001 Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection J Virol 75 5 2377 2387 11160741 PMC114821
  100. Smith SC Allen PM 1991 Myosin-induced acute myocarditis is a T cell-mediated disease J Immunol 147 7 2141 2147 1918949
  101. Smith SC Allen PM 1992 Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis Proceedings of the National Academy of Sciences USA 89 9131 9135 PMC50079 1409614
  102. Smith SC Allen PM 1992 Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis Circ Res 70 856 863 1551208
  103. Smith SC Ladenson JH 1997 Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates Circulation 95 1 163 168 8994432
  104. Sonderegger I Rohn TA 2006 Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis Eur J Immunol 36 11 2849 2856 17039570
  105. Stavrakis S Yu X 2009 Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves’ hyperthyroidism J Am Coll Cardiol 54 14 1309 1316 19778674 PMC2801559
  106. Tobacman LS Adelstein RS 1984 Enzymatic comparisons between light chain isozymes of human cardiac myosin subfragment-1 J Biol Chem 259 18 11226 11230 6147352
  107. Towbin JA Bowles KR 1999 Etiologies of cardiomyopathy and heart failure Nature Medicine 5 766 767 10086375
  108. Tsueng G Tabor-Godwin JM 2011 Coxsackievirus preferentially replicates and induces cytopathic effects in undifferentiated neural progenitor cells J Virol 85 12 5718 5732 21471247 PMC3126326
  109. Wang J I Okazaki M 2010 PD-1 deficiency results in the development of fatal myocarditis in MRL mice Int Immunol 22 6 443 452 20410257
  110. Wegmann KW Zhao W 1994 Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat Journal of Immunology 153 892 900 8021520
  111. Wessely R Klingel K 2001 Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication Circulation 103 5 756 761 11156890
  112. Wolfgram LJ Beisel KW 1986 Variations in the susceptibility to coxsackievirus B3-ionduced myocarditis among different strains of mice J Immunol 136 1846 1852 3005402
  113. Woodruff JF 1980 Viral myocarditis- a review American Journal of Pathology 101 425 466 6254364 PMC1903609
  114. Zabriskie JB 1985 Rheumatic fever: the interplay between host, genetics and microbe Circulation 71 1077 1086 3995703

Authors
Myers, J. M., Fairweather, D., Huber, S. A., & Cunningham, M. W.
Affiliations
  • University of Oklahoma Health Sciences Center (US)
  • Johns Hopkins University (US)
  • University of Vermont (US)
Venue
Current Protocols in Immunology
Publisher
Wiley
Published
2013-04
Volume
101
Issue
1
Pages
Unit 15.14.1-51
ISSN
  • 1934-3671 (ISSN-L)
  • 1934-368X
OpenAlex
W1627734560
Cited by
63
References
137
Citations by year
2026: 3 · 2025: 3 · 2024: 9 · 2023: 8 · 2022: 4 · 2021: 9 · 2020: 4 · 2019: 5 · 2018: 5 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 5 · 2013: 2
FWCI
2.72
Type
journal article
Language
en
Open access
Locations
  • Current Protocols in Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01HL087033, R56HL056267, R01HL111938, R01HL056267, HL111938, R01HL108371, R37HL035280)
  • National Institute of Allergy and Infectious Diseases (T32AI007633)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
experimental autoimmune myocarditis, valvulitis, dilated cardiomyopathy, autoantibodies, T cells, coxsackievirus B3, animal models, Lewis rats, mouse strains, rheumatic heart disease, autoimmunity
MeSH terms
Animals, Autoantibodies, Autoantigens, Autoimmune Diseases, Coxsackievirus Infections, Disease Models, Animal, Enterovirus, Heart Valves, Humans, Inflammation, Cardiomyopathies, Myocarditis, Receptors, Adrenergic, beta, Receptors, Muscarinic, Autoimmunity, Gene Expression, Cardiac Myosins, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review